Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Olaparib
100%
Uterine Carcinosarcoma
100%
Ovarian Carcinosarcoma
100%
Poly(adenosine diphosphate-ribose) Polymerase inhibitor
100%
Signature 3
100%
Homologous Recombination Deficiency
100%
Carcinosarcoma
90%
Sequence Data
20%
Xenograft
20%
Whole Exome Sequencing
20%
PARP Inhibitors (PARPi)
20%
Cell Growth
10%
Apoptosis
10%
Antitumor Activity
10%
Cell Cycle Arrest
10%
IC50
10%
DNA Repair
10%
Cell Apoptosis
10%
Cell Viability
10%
Uterus
10%
Poor Survival
10%
Primary Tumor
10%
Tumor Samples
10%
Primary Cells
10%
M Phase
10%
Highly Aggressive
10%
Targeted Agents
10%
Xenograft Tumor Growth
10%
Malignancy-associated
10%
Apoptosis Assay
10%
Viability Cell
10%
Animal Survival
10%
Cell Cytotoxicity Assay
10%
Cell Cycle Assay
10%
Medicine and Dentistry
Poly ADP Ribose Polymerase
100%
Homologous Recombination
100%
Carcinosarcoma
100%
Olaparib
100%
Cell Line
25%
Xenograft
18%
Scanning Electron Microscopy
12%
PARP Inhibitor
12%
Exome Sequencing
12%
Programmed Cell Death
6%
Neoplasm
6%
Tumor Progression
6%
In Vitro
6%
Cell Viability
6%
Cancer
6%
Cytotoxicity Assay
6%
DNA Repair
6%
Cell Growth
6%
IC50
6%
Clinical Study
6%
Primary Tumor
6%
Antineoplastic Activity
6%
Cell Cycle M Phase
6%
Cell Cycle Arrest
6%
Cell Cycle Checkpoint
6%
Apoptosis Assay
6%
Cell Cycle Assay
6%
Primary Cell Line
6%
Biochemistry, Genetics and Molecular Biology
Poly ADP Ribose Polymerase
100%
Homologous Recombination
100%
Deficiency
100%
Scanning Electron Microscopy
20%
Exome Sequencing
20%
Cell Cycle
10%
Clinical Study
10%
Cell Growth
10%
IC50
10%
Cell Viability
10%
Cell Cycle Arrest
10%
Tumor Progression
10%
Cytotoxicity Assay
10%
DNA Repair
10%
Antineoplastic Activity
10%
Cell Cycle Checkpoint
10%
Cell Cycle M Phase
10%
Primary Cell
10%
Apoptosis Assay
10%
Programmed Cell Death
10%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Carcinosarcoma
100%
Olaparib
100%
Scanning Electron Microscopy
12%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
12%
Tumor Growth
6%
Neoplasm
6%
Clinical Study
6%
Antitumor Activity
6%
IC50
6%
Cell Viability
6%
Cytotoxicity Assay
6%
Primary Tumor
6%
Apoptosis Assay
6%
Immunology and Microbiology
Homologous Recombination
100%
Cell Line
40%
Xenograft
30%
Scanning Electron Microscopy
20%
Whole Exome Sequencing
20%
Programmed Cell Death
20%
Cell Cycle
10%
Ovary
10%
Antineoplastic Activity
10%
Cytotoxicity
10%
Cell Cycle Arrest
10%
Cell Growth
10%
IC50
10%
DNA Repair
10%
Cell Viability
10%
Cell Cycle Checkpoint
10%
Primary Cell Line
10%
Cell Cycle M Phase
10%
In Vitro
10%